×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Arrowhead Pharmaceuticals Inc.. (ARWR) NASDAQ

$24.70 (0.98) (-3.82%)

Market Cap: $3.06B

As of 04/12/24 04:00 PM EDT. Market closed.

(ARWR)

Arrowhead Pharmaceuticals Inc.. (ARWR)
NASDAQ

$24.70
(0.98) (-3.82%)

Market Cap: $3.06B

As of 04/12/24 04:00 PM EDT. Market closed.

Add to Portfolio

arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a ... read more

arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. our rnai-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. our targeted rnai molecule (trimtm) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. the trim platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Christopher Anzalone
Full Time Employees
377
CEO Compensation (Base)
$643,012
CEO Compensation (Total)
$1.62M
URL
Address
177 E Colorado Blvd, Suite 700, California, Pasadena, 91105.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Christopher Anzalone
Full Time Employees
377
CEO Compensation (Base)
$643,012
CEO Compensation (Total)
$1.62M
Address
177 E Colorado Blvd, Suite 700, California, Pasadena, 91105.
PRICE CHART FOR ARROWHEAD PHARMACEUTICALS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$25.31
Previous Close
$25.68
Days Range
$24.47 - $25.50
52 week range
$20.67 - $42.48
Volume
856,153
Avg. Volume (30 days)
984,576
Market Cap
$3.06B
Dividend Yield
-
P/E
(10.31)
Shares Outstanding
123,896,914
Open
$25.31
Previous Close
$25.68
Days Range
$24.47 - $25.50
52 week range
$20.67 - $42.48
Volume
856,153
Avg. Volume (30 days)
984,576
Market Cap
$3.06B
Dividend Yield
-
P/E
(10.31)
Shares Outstanding
123,896,914
FINANCIAL STATEMENTS FOR ARROWHEAD PHARMACEUTICALS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARROWHEAD PHARMACEUTICALS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hamilton James CChief Discovery/Trans MedicineApr 01, 2024 Sale$28.036,000168,180204,851Apr 03, 2024, 06:05 PM
Lu HongboDirectorMar 20, 2024 Buy$27.501,00027,50033,680Mar 20, 2024, 07:06 PM
Lu HongboDirectorMar 19, 2024 Buy$28.001,00028,00032,680Mar 20, 2024, 07:06 PM
Lu HongboDirectorMar 18, 2024 Buy$27.491,00027,49031,680Mar 20, 2024, 07:06 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 06, 2024 Sale$35.1940,0001,407,600400,600Mar 08, 2024, 05:54 PM
Anzalone Christopher RichardChief Executive OfficerJan 31, 2024 Option Exercise$14.5457,499836,0353,772,547Feb 02, 2024, 05:25 PM
Anzalone Christopher RichardChief Executive OfficerJan 31, 2024 Sale$32.3557,4991,860,0193,734,778Feb 02, 2024, 05:25 PM
Hamilton James CChief Discovery/Trans MedicineJan 12, 2024 Sale$36.897,940292,904214,553Jan 17, 2024, 06:32 PM
GIVEN DOUGLAS BDirectorJan 11, 2024 Sale$38.062,911110,788130,811Jan 16, 2024, 06:06 PM
Waddill William D.DirectorJan 11, 2024 Sale$38.073,934149,75949,170Jan 16, 2024, 06:06 PM
Ferrari MauroDirectorJan 11, 2024 Sale$38.063,147119,78761,778Jan 16, 2024, 06:06 PM
Vakiener VictoriaDirectorJan 11, 2024 Sale$38.104,720179,81333,101Jan 16, 2024, 06:06 PM
Oliver TracieChief Commercial OfficerJan 05, 2024 Sale$33.89742,508136,501Jan 08, 2024, 05:17 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 05, 2024 Sale$35.2716,104567,910455,304Jan 08, 2024, 05:16 PM
San Martin JavierChief Medical OfficerJan 05, 2024 Sale$35.268,303292,804206,000Jan 08, 2024, 05:16 PM
Hamilton James CChief Discovery/Trans MedicineJan 05, 2024 Sale$35.1832,1431,130,748249,134Jan 05, 2024, 08:02 PM
Hamilton James CChief Discovery/Trans MedicineJan 03, 2024 Sale$32.196,300202,781178,734Jan 05, 2024, 08:02 PM
O'Brien PatrickCOO and General CounselJan 03, 2024 Sale$32.288,749282,439408,726Jan 05, 2024, 07:58 PM
O'Brien PatrickCOO and General CounselJan 05, 2024 Sale$35.2722,841805,716485,326Jan 05, 2024, 07:58 PM
O'Brien PatrickCOO and General CounselJan 04, 2024 Sale$32.631,60052,208402,226Jan 05, 2024, 07:58 PM
Anzalone Christopher RichardChief Executive OfficerJan 02, 2024 Sale$31.019,952308,6373,720,366Jan 04, 2024, 05:25 PM
Anzalone Christopher RichardChief Executive OfficerDec 20, 2023 Sale$28.5412,000342,4803,725,000Dec 22, 2023, 05:04 PM
Ferrari MauroDirectorDec 15, 2023 Option Exercise$25.4114,987380,82065,825Dec 19, 2023, 04:03 PM
PERRY MICHAEL SDirectorDec 15, 2023 Option Exercise$25.4114,987380,820114,754Dec 19, 2023, 03:55 PM
OLUKOTUN ADEOYE YDirectorDec 15, 2023 Option Exercise$25.4114,987380,82022,854Dec 19, 2023, 03:54 PM
Vakiener VictoriaDirectorDec 15, 2023 Option Exercise$25.4114,987380,82036,721Dec 19, 2023, 03:52 PM
GIVEN DOUGLAS BDirectorDec 15, 2023 Option Exercise$25.4114,987380,820132,622Dec 19, 2023, 03:51 PM
Waddill William D.DirectorDec 15, 2023 Option Exercise$25.4114,987380,82051,804Dec 19, 2023, 03:41 PM
San Martin JavierChief Medical OfficerNov 20, 2023 Sale$28.8019,700567,315136,742Nov 22, 2023, 02:31 PM
Anzalone Christopher RichardChief Executive OfficerOct 25, 2023 Sale$24.2124,338589,2233,737,000Oct 27, 2023, 06:23 PM
Vakiener VictoriaDirectorSep 28, 2023 Sale$26.331,55040,81121,734Oct 02, 2023, 05:51 PM
Anzalone Christopher RichardChief Executive OfficerSep 18, 2023 Option Exercise$4.7557,755274,3363,819,093Sep 20, 2023, 06:10 PM
Anzalone Christopher RichardChief Executive OfficerSep 18, 2023 Sale$28.1257,7551,624,2233,787,570Sep 20, 2023, 06:10 PM
Oliver TracieChief Commercial OfficerJul 03, 2023 Sale$35.318,925315,14261,575Jul 06, 2023, 06:04 PM
Hamilton James CChief Discovery/Trans MedicineJun 30, 2023 Sale$35.533,000106,590188,484Jul 05, 2023, 06:15 PM
Myszkowski Kenneth AllenChief Financial OfficerJun 27, 2023 Sale$36.2015,000543,000381,704Jun 29, 2023, 06:41 PM
GIVEN DOUGLAS BDirectorMay 05, 2023 Sale$40.906,500265,850117,635May 08, 2023, 06:29 PM
Anzalone Christopher RichardChief Executive OfficerMay 03, 2023 Option Exercise$2.0154,928110,4053,816,266May 05, 2023, 07:04 PM
Anzalone Christopher RichardChief Executive OfficerMay 04, 2023 Option Exercise$2.0150,000100,5003,811,338May 05, 2023, 07:04 PM
Anzalone Christopher RichardChief Executive OfficerMay 03, 2023 Sale$39.1454,9282,149,8823,761,338May 05, 2023, 07:04 PM
Anzalone Christopher RichardChief Executive OfficerMay 04, 2023 Sale$39.5250,0001,975,7923,787,330May 05, 2023, 07:04 PM
OLUKOTUN ADEOYE YDirectorMar 03, 2023 Sale$32.6511,350370,5787,867Mar 06, 2023, 06:04 PM
GIVEN DOUGLAS BDirectorFeb 27, 2023 Sale$32.6287528,54213,000Mar 01, 2023, 06:14 PM
Waddill William D.DirectorJan 09, 2023 Sale$30.003,20096,00028,950Jan 11, 2023, 08:23 PM
O'Brien PatrickCOO and General CounselJan 05, 2023 Sale$37.3915,000560,850420,875Jan 06, 2023, 07:30 PM
Hamilton James CChief Discovery/Trans MedicineJan 05, 2023 Sale$37.4013,803516,232198,057Jan 06, 2023, 07:24 PM
O'Brien PatrickCOO and General CounselJan 03, 2023 Sale$38.3317,500670,802378,222Jan 05, 2023, 07:10 PM
Hamilton James CChief Discovery/Trans MedicineJan 03, 2023 Sale$38.3810,338396,738154,431Jan 05, 2023, 07:05 PM
Myszkowski Kenneth AllenChief Financial OfficerDec 29, 2022 Sale$40.0030,6251,225,000336,704Dec 30, 2022, 05:12 PM
O'Brien PatrickGeneral CounselDec 21, 2022 Option Exercise$6.1532,000196,800380,875Dec 22, 2022, 08:01 PM
San Martin JavierChief Medical OfficerNov 21, 2022 Sale$29.9919,500584,73891,700Nov 22, 2022, 06:05 PM
Anzalone Christopher RichardChief Executive OfficerSep 27, 2022 Option Exercise$30.7940,6241,250,6793,469,856Sep 29, 2022, 05:15 PM
Anzalone Christopher RichardChief Executive OfficerJul 07, 2022 Option Exercise$14.542,50136,3654,060,135Jul 11, 2022, 08:08 PM
Anzalone Christopher RichardChief Executive OfficerFeb 11, 2022 Option Exercise$5.19146,388759,7544,204,022Feb 14, 2022, 08:54 AM
Anzalone Christopher RichardChief Executive OfficerFeb 11, 2022 Sale$51.91146,3887,598,8654,163,169Feb 14, 2022, 08:54 AM
Anzalone Christopher RichardChief Executive OfficerJan 07, 2022 Option Exercise$5.1911,80661,2734,057,634Jan 07, 2022, 09:39 PM
O'Brien PatrickGeneral CounselJan 05, 2022 Sale$61.7232,5002,005,875368,941Jan 07, 2022, 08:16 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 05, 2022 Sale$61.7040,0002,467,941488,097Jan 06, 2022, 08:58 PM
Hamilton James CSenior Vice PresidentJan 05, 2022 Sale$61.726,250385,773159,585Jan 06, 2022, 08:56 PM
Hamilton James CSenior Vice PresidentJan 04, 2022 Sale$65.4919,3751,268,818171,295Jan 06, 2022, 08:56 PM
Waddill William D.DirectorJan 03, 2022 Sale$64.724,500291,24428,150Jan 04, 2022, 09:35 PM
OLUKOTUN ADEOYE YDirectorJan 03, 2022 Sale$64.754,050262,2337,110Jan 04, 2022, 09:33 PM
De Backer MarianneDirectorJan 03, 2022 Sale$64.714,500291,17719,256Jan 04, 2022, 09:31 PM
PERRY MICHAEL SDirectorJan 03, 2022 Sale$64.714,500291,19287,372Jan 04, 2022, 09:30 PM
O'Brien PatrickGeneral CounselDec 31, 2021 Option Exercise$6.1528,000172,200321,375Jan 04, 2022, 09:26 PM
GIVEN DOUGLAS BDirectorDec 28, 2021 Buy$66.3765543,472109,868Dec 29, 2021, 08:44 PM
Ferrari MauroDirectorDec 28, 2021 Sale$66.823,400227,18836,571Dec 29, 2021, 08:41 PM
Anzalone Christopher RichardChief Executive OfficerDec 23, 2021 Option Exercise$5.1911,80661,2733,245,828Dec 23, 2021, 09:52 PM
Anzalone Christopher RichardChief Executive OfficerDec 15, 2021 Sale$67.5660,0004,053,4313,253,165Dec 17, 2021, 08:14 PM
San Martin JavierChief Medical OfficerNov 19, 2021 Sale$69.3119,5001,351,589116,796Nov 22, 2021, 04:56 PM
Anzalone Christopher RichardChief Executive OfficerOct 20, 2021 Sale$66.2315,000993,4503,329,022Oct 22, 2021, 05:58 PM
Anzalone Christopher RichardChief Executive OfficerOct 22, 2021 Sale$65.6350,0003,281,5323,284,852Oct 22, 2021, 05:58 PM
OLUKOTUN ADEOYE YDirectorSep 13, 2021 Sale$63.765,000318,80011,750Sep 14, 2021, 05:25 PM
GIVEN DOUGLAS BDirectorSep 09, 2021 Sale$65.245,000326,200109,868Sep 10, 2021, 04:53 PM
De Backer MarianneDirectorJun 24, 2021 Sale$89.855,000449,25021,500Jun 25, 2021, 06:59 PM
Hassard JamesChief Commercial OfficerJun 22, 2021 Sale$89.223,625323,423105,750Jun 24, 2021, 06:44 PM
GIVEN DOUGLAS BDirectorFeb 22, 2021 Sale$88.731,12599,82113,875Feb 24, 2021, 06:51 PM
O'Brien PatrickGeneral CounselFeb 08, 2021 Option Exercise$5.2290,000469,800383,375Feb 10, 2021, 05:56 PM
O'Brien PatrickGeneral CounselFeb 08, 2021 Sale$88.4690,0007,961,240375,414Feb 10, 2021, 05:56 PM
GIVEN DOUGLAS BDirectorJan 15, 2021 Sale$83.283,000249,84012,500Jan 19, 2021, 05:58 PM
Hamilton James CSenior Vice PresidentJan 14, 2021 Sale$81.2910,000812,942130,064Jan 15, 2021, 05:49 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 12, 2021 Sale$81.001,441116,721444,005Jan 12, 2021, 06:06 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 11, 2021 Sale$81.0211,597939,589445,446Jan 12, 2021, 06:06 PM
Hassard JamesChief Commercial OfficerJan 07, 2021 Sale$75.0015,6251,171,875109,375Jan 08, 2021, 06:05 PM
O'Brien PatrickGeneral CounselJan 06, 2021 Sale$72.4125,0001,810,346317,233Jan 07, 2021, 06:11 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 06, 2021 Sale$72.4430,6252,218,477486,568Jan 07, 2021, 06:08 PM
Hamilton James CSenior Vice PresidentJan 06, 2021 Sale$72.4819,3751,404,276154,925Jan 07, 2021, 06:02 PM
Hamilton James CSenior Vice PresidentJan 05, 2021 Sale$72.5319,3751,405,303171,200Jan 07, 2021, 06:02 PM
PERRY MICHAEL SDirectorJan 04, 2021 Sale$76.094,000304,36090,000Jan 05, 2021, 06:14 PM
GIVEN DOUGLAS BDirectorJan 04, 2021 Sale$76.084,000304,320119,368Jan 05, 2021, 06:11 PM
Waddill William D.DirectorJan 04, 2021 Sale$76.083,750285,30030,250Jan 05, 2021, 06:01 PM
Anzalone Christopher RichardChief Executive OfficerDec 18, 2020 Option Exercise$5.7340,510232,0062,545,747Dec 22, 2020, 05:55 PM
GIVEN DOUGLAS BDirectorDec 17, 2020 Sale$79.5950039,79515,000Dec 18, 2020, 06:26 PM
GIVEN DOUGLAS BDirectorDec 17, 2020 Sale$79.309,075719,648114,738Dec 18, 2020, 06:26 PM
Waddill William D.DirectorDec 10, 2020 Sale$71.263,000213,78026,800Dec 11, 2020, 06:16 PM
Anzalone Christopher RichardChief Executive OfficerDec 08, 2020 Option Exercise$2.0116,32432,8112,521,561Dec 10, 2020, 07:07 PM
Anzalone Christopher RichardChief Executive OfficerDec 09, 2020 Option Exercise$2.0138,67677,7392,543,913Dec 10, 2020, 07:07 PM
Anzalone Christopher RichardChief Executive OfficerDec 08, 2020 Sale$67.9716,3241,109,5422,505,237Dec 10, 2020, 07:07 PM
Anzalone Christopher RichardChief Executive OfficerDec 09, 2020 Sale$69.0638,6762,670,8052,527,187Dec 10, 2020, 07:07 PM
Bradshaw CurtChief Scientific OfficerNov 20, 2020 Sale$68.7315,6251,073,9060Nov 23, 2020, 05:58 PM
Bradshaw CurtChief Scientific OfficerNov 19, 2020 Sale$69.3915,6251,084,21915,625Nov 23, 2020, 05:58 PM
San Martin JavierChief Medical OfficerNov 19, 2020 Sale$69.3919,5001,353,105130,500Nov 20, 2020, 06:03 PM
Myszkowski Kenneth AllenChief Financial OfficerNov 09, 2020 Option Exercise$14.5443,505632,563471,173Nov 12, 2020, 05:49 PM
Myszkowski Kenneth AllenChief Financial OfficerNov 09, 2020 Sale$69.3743,5053,018,071445,333Nov 12, 2020, 05:49 PM
De Backer MarianneDirectorOct 08, 2020 Buy$50.471,00050,46517,500Oct 26, 2020, 06:02 PM
Anzalone Christopher RichardChief Executive OfficerOct 23, 2020 Sale$58.21100,0005,821,0322,517,509Oct 23, 2020, 07:35 PM
Myszkowski Kenneth AllenChief Financial OfficerOct 20, 2020 Option Exercise$6.1529,166179,371456,834Oct 22, 2020, 06:02 PM
Myszkowski Kenneth AllenChief Financial OfficerOct 20, 2020 Sale$54.0429,1661,576,131427,668Oct 22, 2020, 06:02 PM
Ferrari MauroDirectorOct 09, 2020 Sale$48.0010,000480,00030,971Oct 13, 2020, 06:01 PM
Anzalone Christopher RichardChief Executive OfficerAug 13, 2020 Option Exercise$9.9050,000495,0002,655,237Aug 14, 2020, 06:08 PM
Anzalone Christopher RichardChief Executive OfficerAug 13, 2020 Sale$41.3550,0002,067,5002,605,237Aug 14, 2020, 06:08 PM
Anzalone Christopher RichardChief Executive OfficerJun 25, 2020 Sale$38.81100,0003,881,0172,605,260Jun 26, 2020, 06:02 PM
De Backer MarianneDirectorMar 11, 2020 Buy$28.6050014,30014,500Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorFeb 28, 2020 Buy$34.3950017,19514,000Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorFeb 27, 2020 Buy$35.0750017,53513,500Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorJun 15, 2020 Buy$31.3350015,66516,500Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorJan 13, 2020 Buy$54.9550027,47513,000Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorApr 15, 2020 Buy$35.4050017,70016,000Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorMar 16, 2020 Buy$23.9450011,97015,500Jun 24, 2020, 06:10 PM
De Backer MarianneDirectorMar 12, 2020 Buy$24.8050012,40015,000Jun 24, 2020, 06:10 PM
PERRY MICHAEL SDirectorMay 14, 2020 Option Exercise$3.7077,000285,20085,000May 18, 2020, 06:27 PM
PERRY MICHAEL SDirectorMay 12, 2020 Sale$35.8336,0001,289,89114,100May 13, 2020, 06:48 PM
Waddill William D.DirectorMay 11, 2020 Sale$36.5426,000950,04028,000May 13, 2020, 06:45 PM
GIVEN BRUCE DChief Operating OfficerApr 28, 2020 Option Exercise$8.614,19736,131855,831Apr 29, 2020, 07:19 PM
GIVEN BRUCE DChief Operating OfficerApr 27, 2020 Option Exercise$5.192001,038851,934Apr 29, 2020, 07:19 PM
GIVEN BRUCE DChief Operating OfficerApr 28, 2020 Sale$40.005,101204,040855,331Apr 29, 2020, 07:19 PM
GIVEN BRUCE DChief Operating OfficerApr 27, 2020 Sale$40.0030012,000851,734Apr 29, 2020, 07:19 PM
GIVEN BRUCE DChief Operating OfficerApr 20, 2020 Option Exercise$8.1416,256132,286875,249Apr 22, 2020, 07:00 PM
GIVEN BRUCE DChief Operating OfficerApr 20, 2020 Sale$40.0023,515940,600871,449Apr 22, 2020, 07:00 PM
GIVEN DOUGLAS BDirectorApr 14, 2020 Sale$36.8925,000922,250155,925Apr 16, 2020, 07:47 PM
Myszkowski Kenneth AllenChief Financial OfficerFeb 25, 2020 Option Exercise$8.8443,445384,145427,668Feb 27, 2020, 05:41 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 21, 2020 Option Exercise$5.1933,351173,092424,536Jan 23, 2020, 06:15 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 21, 2020 Sale$49.4440,3131,992,925418,139Jan 23, 2020, 06:15 PM
GIVEN BRUCE DChief Operating OfficerJan 06, 2020 Sale$60.1335,6132,141,285882,759Jan 08, 2020, 06:35 PM
O'Brien PatrickGeneral CounselJan 06, 2020 Sale$60.1214,625879,261267,406Jan 08, 2020, 06:33 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 06, 2020 Sale$60.1120,0001,202,201403,592Jan 08, 2020, 06:31 PM
Anzalone Christopher RichardChief Executive OfficerDec 24, 2019 Sale$63.5083,3335,291,6461,805,237Dec 27, 2019, 04:54 PM
Anzalone Christopher RichardChief Executive OfficerDec 13, 2019 Sale$66.7383,3335,560,4891,962,952Dec 13, 2019, 06:35 PM
Anzalone Christopher RichardChief Executive OfficerDec 12, 2019 Sale$67.50100,0006,749,6302,048,684Dec 13, 2019, 06:35 PM
Anzalone Christopher RichardChief Executive OfficerDec 03, 2019 Sale$61.5812,033740,9522,079,925Dec 04, 2019, 06:48 PM
Anzalone Christopher RichardChief Executive OfficerDec 02, 2019 Sale$69.1537,9672,625,5702,116,160Dec 04, 2019, 06:48 PM
Myszkowski Kenneth AllenChief Financial OfficerNov 05, 2019 Option Exercise$5.1912,64965,648326,185Nov 07, 2019, 06:45 PM
Myszkowski Kenneth AllenChief Financial OfficerNov 01, 2019 Option Exercise$7.7537,884293,601351,420Nov 01, 2019, 07:32 PM
Myszkowski Kenneth AllenChief Financial OfficerNov 01, 2019 Sale$40.8537,8841,547,378330,156Nov 01, 2019, 07:32 PM
Anzalone Christopher RichardChief Executive OfficerOct 10, 2019 Option Exercise$5.2056,325292,8902,178,228Oct 11, 2019, 07:31 PM
Anzalone Christopher RichardChief Executive OfficerOct 10, 2019 Sale$31.8356,3251,792,8252,121,903Oct 11, 2019, 07:31 PM
Anzalone Christopher RichardChief Executive OfficerSep 25, 2019 Sale$28.2520,000565,0002,121,903Sep 27, 2019, 09:16 PM
Anzalone Christopher RichardChief Executive OfficerSep 23, 2019 Option Exercise$5.1041,755212,9502,183,658Sep 24, 2019, 09:12 PM
Anzalone Christopher RichardChief Executive OfficerSep 20, 2019 Option Exercise$5.104,25021,6752,146,153Sep 24, 2019, 09:12 PM
Anzalone Christopher RichardChief Executive OfficerSep 24, 2019 Option Exercise$5.1066,645339,8892,208,548Sep 24, 2019, 09:12 PM
Anzalone Christopher RichardChief Executive OfficerSep 23, 2019 Sale$29.0441,7551,212,5652,141,903Sep 24, 2019, 09:12 PM
Anzalone Christopher RichardChief Executive OfficerSep 20, 2019 Sale$29.004,250123,2502,141,903Sep 24, 2019, 09:12 PM
Anzalone Christopher RichardChief Executive OfficerSep 24, 2019 Sale$28.2066,6451,879,2402,154,576Sep 24, 2019, 09:12 PM
PERRY MICHAEL SDirectorSep 11, 2019 Sale$30.0085,0002,550,00036,000Sep 11, 2019, 08:09 PM
PERRY MICHAEL SDirectorSep 09, 2019 Sale$28.90100,0002,890,000121,000Sep 11, 2019, 08:09 PM
Ferrari MauroDirectorJun 26, 2019 Sale$27.6117,756490,2431,900Jun 28, 2019, 07:19 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 31, 2019 Option Exercise$4.9435,000172,800313,536Jun 03, 2019, 06:12 PM
O'Brien PatrickGeneral CounselMay 28, 2019 Sale$24.8830,000746,400203,000May 29, 2019, 07:01 PM
Anzalone Christopher RichardChief Executive OfficerMay 24, 2019 Option Exercise$2.1349,448105,1102,141,903May 29, 2019, 06:57 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 21, 2019 Sale$22.0027,071595,562278,536May 22, 2019, 05:44 PM
Anzalone Christopher RichardChief Executive OfficerApr 03, 2019 Sale$19.3050,000965,0002,092,455Apr 05, 2019, 06:57 PM
GIVEN BRUCE DChief Operating OfficerMar 01, 2019 Option Exercise$2.0142,50085,425687,106Mar 01, 2019, 08:42 PM
GIVEN BRUCE DChief Operating OfficerMar 01, 2019 Sale$19.9942,500849,575644,606Mar 01, 2019, 08:42 PM
GIVEN BRUCE DChief Operating OfficerFeb 25, 2019 Option Exercise$2.0142,50085,425687,106Feb 27, 2019, 07:08 PM
GIVEN BRUCE DChief Operating OfficerFeb 25, 2019 Sale$18.9842,500806,650644,606Feb 27, 2019, 07:08 PM
GIVEN DOUGLAS BDirectorFeb 26, 2019 Option Exercise$3.9265,000254,570240,130Feb 26, 2019, 07:32 PM
GIVEN DOUGLAS BDirectorFeb 26, 2019 Sale$19.2565,0001,251,250175,130Feb 26, 2019, 07:32 PM
GIVEN DOUGLAS BDirectorFeb 22, 2019 Sale$18.053,00054,150175,130Feb 26, 2019, 07:32 PM
Myszkowski Kenneth AllenChief Financial OfficerFeb 19, 2019 Option Exercise$5.208,00041,600313,607Feb 20, 2019, 08:12 PM
Myszkowski Kenneth AllenChief Financial OfficerFeb 19, 2019 Sale$18.008,000144,000305,607Feb 20, 2019, 08:12 PM
GIVEN BRUCE DChief Operating OfficerFeb 19, 2019 Option Exercise$2.0142,50085,425687,106Feb 20, 2019, 08:09 PM
GIVEN BRUCE DChief Operating OfficerFeb 19, 2019 Sale$17.9842,500764,150644,606Feb 20, 2019, 08:09 PM
GIVEN BRUCE DChief Operating OfficerFeb 15, 2019 Sale$17.6726,250463,838644,606Feb 20, 2019, 08:09 PM
GIVEN BRUCE DChief Operating OfficerFeb 11, 2019 Option Exercise$2.6211,66730,568825,023Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 08, 2019 Option Exercise$2.6211,66730,568859,523Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 12, 2019 Option Exercise$2.0142,50085,425713,356Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 11, 2019 Sale$15.96154,1672,460,995727,856Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 08, 2019 Sale$15.3446,167708,202813,356Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 12, 2019 Sale$17.0642,500725,050670,856Feb 12, 2019, 08:58 PM
GIVEN BRUCE DChief Operating OfficerFeb 05, 2019 Sale$14.4822,500325,800847,856Feb 07, 2019, 08:35 PM
GIVEN BRUCE DChief Operating OfficerFeb 01, 2019 Sale$13.8528,500394,725870,356Feb 01, 2019, 07:51 PM
GIVEN BRUCE DChief Operating OfficerJan 23, 2019 Sale$13.1517,500230,125898,856Jan 24, 2019, 08:53 PM
GIVEN BRUCE DChief Operating OfficerJan 22, 2019 Sale$13.59152,0002,065,680916,356Jan 24, 2019, 08:53 PM
GIVEN DOUGLAS BDirectorJan 22, 2019 Sale$13.583,00040,740178,130Jan 24, 2019, 08:46 PM
O'Brien PatrickGeneral CounselJan 18, 2019 Sale$14.4372,0001,038,960233,000Jan 18, 2019, 07:02 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 17, 2019 Sale$14.5581,8751,191,281305,607Jan 18, 2019, 07:00 PM
Li ZhenSnr. VP, Chem and Non-Clin DevJan 14, 2019 Sale$14.3440,500580,770201,700Jan 16, 2019, 08:24 PM
GIVEN BRUCE DChief Operating OfficerJan 14, 2019 Option Exercise$2.9012,66636,7651,111,022Jan 16, 2019, 08:18 PM
GIVEN BRUCE DChief Operating OfficerJan 14, 2019 Sale$14.4042,666614,3901,068,356Jan 16, 2019, 08:18 PM
Waddill William D.DirectorJan 11, 2019 Sale$14.778,500125,54546,500Jan 11, 2019, 06:15 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 02, 2019 Sale$11.988,33399,829387,482Jan 03, 2019, 07:55 PM
GIVEN BRUCE DChief Operating OfficerJan 02, 2019 Sale$11.9820,000239,6001,098,356Jan 03, 2019, 07:53 PM
GIVEN DOUGLAS BDirectorDec 27, 2018 Sale$12.003,00036,000145,130Dec 28, 2018, 05:20 PM
Anzalone Christopher RichardChief Executive OfficerDec 19, 2018 Sale$13.9290,0001,252,8001,542,455Dec 21, 2018, 05:15 PM
Anzalone Christopher RichardChief Executive OfficerDec 12, 2018 Sale$14.0790,0001,266,3001,632,455Dec 14, 2018, 05:18 PM
GIVEN DOUGLAS BDirectorNov 23, 2018 Sale$12.743,00038,220148,130Nov 26, 2018, 09:09 PM
Anzalone Christopher RichardChief Executive OfficerNov 09, 2018 Sale$14.3981,5001,172,7051,727,755Nov 09, 2018, 07:01 PM
Leone Peter BrianVP, Strategic Bus. InitiativesOct 19, 2018 Option Exercise$6.20131,137812,512261,137Oct 23, 2018, 07:59 PM
Leone Peter BrianVP, Strategic Bus. InitiativesOct 19, 2018 Sale$13.49131,1371,769,038130,000Oct 23, 2018, 07:59 PM
Myszkowski Kenneth AllenChief Financial OfficerSep 06, 2018 Option Exercise$3.5745,000160,500355,815Sep 10, 2018, 06:32 PM
Myszkowski Kenneth AllenChief Financial OfficerSep 06, 2018 Sale$19.3445,000870,200330,815Sep 10, 2018, 06:32 PM
Anzalone Christopher RichardChief Executive OfficerSep 04, 2018 Sale$14.4564,834936,8511,803,955Sep 05, 2018, 04:23 PM
Anzalone Christopher RichardChief Executive OfficerAug 31, 2018 Sale$14.45100,0001,445,0001,868,789Sep 05, 2018, 04:23 PM
Myszkowski Kenneth AllenChief Financial OfficerJun 19, 2018 Option Exercise$2.0120,00040,200330,815Jun 20, 2018, 09:18 PM
Myszkowski Kenneth AllenChief Financial OfficerJun 19, 2018 Sale$14.0120,000280,200310,815Jun 20, 2018, 09:18 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 30, 2018 Option Exercise$2.011,4002,814312,215Jun 01, 2018, 05:34 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 31, 2018 Option Exercise$2.0112,60025,326323,415Jun 01, 2018, 05:34 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 30, 2018 Sale$11.001,40015,400310,815Jun 01, 2018, 05:34 PM
Myszkowski Kenneth AllenChief Financial OfficerMay 31, 2018 Sale$11.0012,600138,600310,815Jun 01, 2018, 05:34 PM
GIVEN DOUGLAS BDirectorApr 24, 2018 Sale$6.6325,000165,750155,000Apr 25, 2018, 07:40 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 27, 2018 Option Exercise$2.0120,00040,200330,815Mar 27, 2018, 07:46 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 27, 2018 Sale$8.0020,000160,000310,815Mar 27, 2018, 07:46 PM
Anzalone Christopher RichardChief Executive OfficerMar 16, 2018 Sale$7.4026,000192,4001,968,789Mar 16, 2018, 06:09 PM
Anzalone Christopher RichardChief Executive OfficerMar 14, 2018 Sale$7.44100,000744,0002,094,789Mar 15, 2018, 06:58 PM
Anzalone Christopher RichardChief Executive OfficerMar 13, 2018 Sale$7.43100,000743,0002,194,789Mar 15, 2018, 06:58 PM
Anzalone Christopher RichardChief Executive OfficerMar 15, 2018 Sale$7.41100,000741,0001,994,789Mar 15, 2018, 06:58 PM
GIVEN BRUCE DChief Operating OfficerMar 05, 2018 Sale$6.7320,000134,600908,356Mar 05, 2018, 08:48 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 05, 2018 Option Exercise$6.668,20854,665310,815Mar 05, 2018, 08:46 PM
GIVEN BRUCE DChief Operating OfficerJan 01, 2018 Sale$3.6920,00073,800928,356Jan 03, 2018, 07:25 PM
Anzalone Christopher RichardChief Executive OfficerDec 13, 2016 Option Exercise$1.27300,444381,564816,789Dec 15, 2016, 09:46 PM
GIVEN DOUGLAS BDirectorOct 14, 2016 Sale$6.7212,00080,64070,000Oct 18, 2016, 07:53 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 23, 2016 Option Exercise$2.016,90013,869122,589Aug 26, 2016, 05:52 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 22, 2016 Option Exercise$2.0113,10026,331128,789Aug 26, 2016, 05:52 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 23, 2016 Sale$8.006,90055,200115,689Aug 26, 2016, 05:52 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 22, 2016 Sale$8.0013,100104,800115,689Aug 26, 2016, 05:52 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 22, 2016 Option Exercise$2.0113,10026,331128,789Aug 24, 2016, 06:39 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 23, 2016 Option Exercise$2.016,90013,869122,589Aug 24, 2016, 06:39 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 22, 2016 Sale$8.0013,100104,800115,689Aug 24, 2016, 06:39 PM
Myszkowski Kenneth AllenChief Financial OfficerAug 23, 2016 Sale$8.006,90055,200115,689Aug 24, 2016, 06:39 PM
Anzalone Christopher RichardChief Executive OfficerJun 30, 2016 Option Exercise$5.0915,77280,2791,117,233Jul 05, 2016, 06:11 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 04, 2016 Option Exercise$4.336,26327,119115,689Mar 08, 2016, 06:39 PM
GIVEN BRUCE DChief Operating OfficerMar 04, 2016 Option Exercise$4.3313,67559,213393,356Mar 08, 2016, 06:36 PM
Myszkowski Kenneth AllenChief Financial OfficerFeb 06, 2016 Option Exercise$3.4613,04845,146121,952Feb 09, 2016, 06:45 PM
GIVEN BRUCE DChief Operating OfficerFeb 06, 2016 Option Exercise$3.4617,96962,173407,031Feb 09, 2016, 06:41 PM
Myszkowski Kenneth AllenChief Financial OfficerDec 30, 2015 Option Exercise$6.1313,15380,628108,347Jan 04, 2016, 07:19 PM
Myszkowski Kenneth AllenChief Financial OfficerDec 30, 2015 Sale$6.1323,347143,11785,000Jan 04, 2016, 07:19 PM
Anzalone Christopher RichardChief Executive OfficerDec 30, 2015 Option Exercise$6.1358,712359,905561,461Jan 04, 2016, 07:15 PM
Ferrari MauroDirectorOct 28, 2013 Buy$7.624003,0474,251Jan 14, 2015, 06:10 PM
Ferrari MauroDirectorOct 09, 2013 Buy$6.191,90011,7613,851Jan 14, 2015, 06:10 PM
Lewis David L.Chief Scientific OfficerJan 05, 2015 Option Exercise$2.0115,00030,15015,000Jan 07, 2015, 05:50 PM
Lewis David L.Chief Scientific OfficerJan 05, 2015 Sale$8.0115,000120,1030Jan 07, 2015, 05:50 PM
Anzalone Christopher RichardPresident and CEOOct 15, 2014 Buy$6.3216,000101,120260,173Oct 15, 2014, 06:33 PM
Anzalone Christopher RichardPresident and CEOOct 15, 2014 Buy$6.3216,000101,120260,173Oct 15, 2014, 05:31 PM
McKenney CharlesDirectorOct 01, 2014 Option Exercise$5.192,50012,97519,720Oct 01, 2014, 07:38 PM
McKenney CharlesDirectorOct 01, 2014 Sale$14.702,50036,74817,220Oct 01, 2014, 07:38 PM
Lewis David L.Chief Scientific OfficerSep 30, 2014 Option Exercise$2.0115,00030,15015,000Sep 30, 2014, 05:59 PM
Lewis David L.Chief Scientific OfficerSep 30, 2014 Sale$15.0215,000225,3500Sep 30, 2014, 05:59 PM
GIVEN DOUGLAS BDirectorSep 26, 2014 Option Exercise$2.192,0004,38022,000Sep 30, 2014, 05:58 PM
GIVEN DOUGLAS BDirectorSep 26, 2014 Sale$15.242,00030,48020,000Sep 30, 2014, 05:58 PM
GIVEN DOUGLAS BDirectorAug 15, 2014 Option Exercise$2.015,00010,05025,000Aug 19, 2014, 05:15 PM
GIVEN DOUGLAS BDirectorAug 15, 2014 Sale$13.905,00069,50020,000Aug 19, 2014, 05:15 PM
Myszkowski Kenneth AllenCFOAug 15, 2014 Option Exercise$6.3240,000252,850111,500Aug 19, 2014, 05:15 PM
Myszkowski Kenneth AllenCFOAug 15, 2014 Sale$14.0240,000560,86071,500Aug 19, 2014, 05:15 PM
McKenney CharlesDirectorJun 09, 2014 Option Exercise$2.3922,00052,48039,220Jun 10, 2014, 09:28 PM
McKenney CharlesDirectorJun 09, 2014 Sale$14.3222,000315,00517,220Jun 10, 2014, 09:28 PM
Myszkowski Kenneth AllenCFOFeb 12, 2014 Option Exercise$2.0116,00032,16087,500Feb 12, 2014, 07:15 PM
Myszkowski Kenneth AllenCFOFeb 12, 2014 Sale$18.7716,000300,29071,500Feb 12, 2014, 07:15 PM
FRYKMAN EDWARD WDirectorFeb 07, 2014 Option Exercise$10.005,00050,00027,000Feb 10, 2014, 07:45 PM
FRYKMAN EDWARD WDirectorFeb 07, 2014 Sale$15.983,14850,29623,852Feb 10, 2014, 07:45 PM
Lewis David L.Chief Scientific OfficerJan 02, 2014 Option Exercise$4.3715,00065,52515,000Jan 06, 2014, 05:37 PM
Lewis David L.Chief Scientific OfficerJan 02, 2014 Sale$10.2915,000154,2920Jan 06, 2014, 05:37 PM
McKenney CharlesDirectorOct 11, 2013 Option Exercise$7.581,2009,0962,220Oct 15, 2013, 04:05 PM
Anzalone Christopher RichardPresident and CEOAug 31, 2010 Buy$0.8910,0008,900341,729Aug 31, 2010, 05:58 PM
Anzalone Christopher RichardPresident and CEOAug 27, 2010 Buy$0.8910,0008,900331,729Aug 30, 2010, 04:19 PM
Myszkowski Kenneth AllenCFOAug 27, 2010 Buy$0.8915,00013,35015,000Aug 30, 2010, 04:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hamilton James CChief Discovery/Trans Medicine04/01/2024168,180
Lu HongboDirector03/20/202427,500
Lu HongboDirector03/19/202428,000
Lu HongboDirector03/18/202427,490
Myszkowski Kenneth AllenChief Financial Officer03/06/20241,407,600
Anzalone Christopher RichardChief Executive Officer01/31/2024836,035
Anzalone Christopher RichardChief Executive Officer01/31/20241,860,019
Hamilton James CChief Discovery/Trans Medicine01/12/2024292,904
GIVEN DOUGLAS BDirector01/11/2024110,788
Waddill William D.Director01/11/2024149,759
Ferrari MauroDirector01/11/2024119,787
Vakiener VictoriaDirector01/11/2024179,813
Oliver TracieChief Commercial Officer01/05/20242,508
Myszkowski Kenneth AllenChief Financial Officer01/05/2024567,910
San Martin JavierChief Medical Officer01/05/2024292,804
Hamilton James CChief Discovery/Trans Medicine01/05/20241,130,748
Hamilton James CChief Discovery/Trans Medicine01/03/2024202,781
O'Brien PatrickCOO and General Counsel01/03/2024282,439
O'Brien PatrickCOO and General Counsel01/05/2024805,716
O'Brien PatrickCOO and General Counsel01/04/202452,208
Anzalone Christopher RichardChief Executive Officer01/02/2024308,637
Anzalone Christopher RichardChief Executive Officer12/20/2023342,480
Ferrari MauroDirector12/15/2023380,820
PERRY MICHAEL SDirector12/15/2023380,820
OLUKOTUN ADEOYE YDirector12/15/2023380,820
Vakiener VictoriaDirector12/15/2023380,820
GIVEN DOUGLAS BDirector12/15/2023380,820
Waddill William D.Director12/15/2023380,820
San Martin JavierChief Medical Officer11/20/2023567,315
Anzalone Christopher RichardChief Executive Officer10/25/2023589,223
Vakiener VictoriaDirector09/28/202340,811
Anzalone Christopher RichardChief Executive Officer09/18/2023274,336
Anzalone Christopher RichardChief Executive Officer09/18/20231,624,223
Oliver TracieChief Commercial Officer07/03/2023315,142
Hamilton James CChief Discovery/Trans Medicine06/30/2023106,590
Myszkowski Kenneth AllenChief Financial Officer06/27/2023543,000
GIVEN DOUGLAS BDirector05/05/2023265,850
Anzalone Christopher RichardChief Executive Officer05/03/2023110,405
Anzalone Christopher RichardChief Executive Officer05/04/2023100,500
Anzalone Christopher RichardChief Executive Officer05/03/20232,149,882
Anzalone Christopher RichardChief Executive Officer05/04/20231,975,792
OLUKOTUN ADEOYE YDirector03/03/2023370,578
GIVEN DOUGLAS BDirector02/27/202328,542
Waddill William D.Director01/09/202396,000
O'Brien PatrickCOO and General Counsel01/05/2023560,850
Hamilton James CChief Discovery/Trans Medicine01/05/2023516,232
O'Brien PatrickCOO and General Counsel01/03/2023670,802
Hamilton James CChief Discovery/Trans Medicine01/03/2023396,738
Myszkowski Kenneth AllenChief Financial Officer12/29/20221,225,000
O'Brien PatrickGeneral Counsel12/21/2022196,800
San Martin JavierChief Medical Officer11/21/2022584,738
Anzalone Christopher RichardChief Executive Officer09/27/20221,250,679
Anzalone Christopher RichardChief Executive Officer07/07/202236,365
Anzalone Christopher RichardChief Executive Officer02/11/2022759,754
Anzalone Christopher RichardChief Executive Officer02/11/20227,598,865
Anzalone Christopher RichardChief Executive Officer01/07/202261,273
O'Brien PatrickGeneral Counsel01/05/20222,005,875
Myszkowski Kenneth AllenChief Financial Officer01/05/20222,467,941
Hamilton James CSenior Vice President01/05/2022385,773
Hamilton James CSenior Vice President01/04/20221,268,818
Waddill William D.Director01/03/2022291,244
OLUKOTUN ADEOYE YDirector01/03/2022262,233
De Backer MarianneDirector01/03/2022291,177
PERRY MICHAEL SDirector01/03/2022291,192
O'Brien PatrickGeneral Counsel12/31/2021172,200
GIVEN DOUGLAS BDirector12/28/202143,472
Ferrari MauroDirector12/28/2021227,188
Anzalone Christopher RichardChief Executive Officer12/23/202161,273
Anzalone Christopher RichardChief Executive Officer12/15/20214,053,431
San Martin JavierChief Medical Officer11/19/20211,351,589
Anzalone Christopher RichardChief Executive Officer10/20/2021993,450
Anzalone Christopher RichardChief Executive Officer10/22/20213,281,532
OLUKOTUN ADEOYE YDirector09/13/2021318,800
GIVEN DOUGLAS BDirector09/09/2021326,200
De Backer MarianneDirector06/24/2021449,250
Hassard JamesChief Commercial Officer06/22/2021323,423
GIVEN DOUGLAS BDirector02/22/202199,821
O'Brien PatrickGeneral Counsel02/08/2021469,800
O'Brien PatrickGeneral Counsel02/08/20217,961,240
GIVEN DOUGLAS BDirector01/15/2021249,840
Hamilton James CSenior Vice President01/14/2021812,942
Myszkowski Kenneth AllenChief Financial Officer01/12/2021116,721
Myszkowski Kenneth AllenChief Financial Officer01/11/2021939,589
Hassard JamesChief Commercial Officer01/07/20211,171,875
O'Brien PatrickGeneral Counsel01/06/20211,810,346
Myszkowski Kenneth AllenChief Financial Officer01/06/20212,218,477
Hamilton James CSenior Vice President01/06/20211,404,276
Hamilton James CSenior Vice President01/05/20211,405,303
PERRY MICHAEL SDirector01/04/2021304,360
GIVEN DOUGLAS BDirector01/04/2021304,320
Waddill William D.Director01/04/2021285,300
Anzalone Christopher RichardChief Executive Officer12/18/2020232,006
GIVEN DOUGLAS BDirector12/17/202039,795
GIVEN DOUGLAS BDirector12/17/2020719,648
Waddill William D.Director12/10/2020213,780
Anzalone Christopher RichardChief Executive Officer12/08/202032,811
Anzalone Christopher RichardChief Executive Officer12/09/202077,739
Anzalone Christopher RichardChief Executive Officer12/08/20201,109,542
Anzalone Christopher RichardChief Executive Officer12/09/20202,670,805
Bradshaw CurtChief Scientific Officer11/20/20201,073,906
Bradshaw CurtChief Scientific Officer11/19/20201,084,219
San Martin JavierChief Medical Officer11/19/20201,353,105
Myszkowski Kenneth AllenChief Financial Officer11/09/2020632,563
Myszkowski Kenneth AllenChief Financial Officer11/09/20203,018,071
De Backer MarianneDirector10/08/202050,465
Anzalone Christopher RichardChief Executive Officer10/23/20205,821,032
Myszkowski Kenneth AllenChief Financial Officer10/20/2020179,371
Myszkowski Kenneth AllenChief Financial Officer10/20/20201,576,131
Ferrari MauroDirector10/09/2020480,000
Anzalone Christopher RichardChief Executive Officer08/13/2020495,000
Anzalone Christopher RichardChief Executive Officer08/13/20202,067,500
Anzalone Christopher RichardChief Executive Officer06/25/20203,881,017
De Backer MarianneDirector03/11/202014,300
De Backer MarianneDirector02/28/202017,195
De Backer MarianneDirector02/27/202017,535
De Backer MarianneDirector06/15/202015,665
De Backer MarianneDirector01/13/202027,475
De Backer MarianneDirector04/15/202017,700
De Backer MarianneDirector03/16/202011,970
De Backer MarianneDirector03/12/202012,400
PERRY MICHAEL SDirector05/14/2020285,200
PERRY MICHAEL SDirector05/12/20201,289,891
Waddill William D.Director05/11/2020950,040
GIVEN BRUCE DChief Operating Officer04/28/202036,131
GIVEN BRUCE DChief Operating Officer04/27/20201,038
GIVEN BRUCE DChief Operating Officer04/28/2020204,040
GIVEN BRUCE DChief Operating Officer04/27/202012,000
GIVEN BRUCE DChief Operating Officer04/20/2020132,286
GIVEN BRUCE DChief Operating Officer04/20/2020940,600
GIVEN DOUGLAS BDirector04/14/2020922,250
Myszkowski Kenneth AllenChief Financial Officer02/25/2020384,145
Myszkowski Kenneth AllenChief Financial Officer01/21/2020173,092
Myszkowski Kenneth AllenChief Financial Officer01/21/20201,992,925
GIVEN BRUCE DChief Operating Officer01/06/20202,141,285
O'Brien PatrickGeneral Counsel01/06/2020879,261
Myszkowski Kenneth AllenChief Financial Officer01/06/20201,202,201
Anzalone Christopher RichardChief Executive Officer12/24/20195,291,646
Anzalone Christopher RichardChief Executive Officer12/13/20195,560,489
Anzalone Christopher RichardChief Executive Officer12/12/20196,749,630
Anzalone Christopher RichardChief Executive Officer12/03/2019740,952
Anzalone Christopher RichardChief Executive Officer12/02/20192,625,570
Myszkowski Kenneth AllenChief Financial Officer11/05/201965,648
Myszkowski Kenneth AllenChief Financial Officer11/01/2019293,601
Myszkowski Kenneth AllenChief Financial Officer11/01/20191,547,378
Anzalone Christopher RichardChief Executive Officer10/10/2019292,890
Anzalone Christopher RichardChief Executive Officer10/10/20191,792,825
Anzalone Christopher RichardChief Executive Officer09/25/2019565,000
Anzalone Christopher RichardChief Executive Officer09/23/2019212,950
Anzalone Christopher RichardChief Executive Officer09/20/201921,675
Anzalone Christopher RichardChief Executive Officer09/24/2019339,889
Anzalone Christopher RichardChief Executive Officer09/23/20191,212,565
Anzalone Christopher RichardChief Executive Officer09/20/2019123,250
Anzalone Christopher RichardChief Executive Officer09/24/20191,879,240
PERRY MICHAEL SDirector09/11/20192,550,000
PERRY MICHAEL SDirector09/09/20192,890,000
Ferrari MauroDirector06/26/2019490,243
Myszkowski Kenneth AllenChief Financial Officer05/31/2019172,800
O'Brien PatrickGeneral Counsel05/28/2019746,400
Anzalone Christopher RichardChief Executive Officer05/24/2019105,110
Myszkowski Kenneth AllenChief Financial Officer05/21/2019595,562
Anzalone Christopher RichardChief Executive Officer04/03/2019965,000
GIVEN BRUCE DChief Operating Officer03/01/201985,425
GIVEN BRUCE DChief Operating Officer03/01/2019849,575
GIVEN BRUCE DChief Operating Officer02/25/201985,425
GIVEN BRUCE DChief Operating Officer02/25/2019806,650
GIVEN DOUGLAS BDirector02/26/2019254,570
GIVEN DOUGLAS BDirector02/26/20191,251,250
GIVEN DOUGLAS BDirector02/22/201954,150
Myszkowski Kenneth AllenChief Financial Officer02/19/201941,600
Myszkowski Kenneth AllenChief Financial Officer02/19/2019144,000
GIVEN BRUCE DChief Operating Officer02/19/201985,425
GIVEN BRUCE DChief Operating Officer02/19/2019764,150
GIVEN BRUCE DChief Operating Officer02/15/2019463,838
GIVEN BRUCE DChief Operating Officer02/11/201930,568
GIVEN BRUCE DChief Operating Officer02/08/201930,568
GIVEN BRUCE DChief Operating Officer02/12/201985,425
GIVEN BRUCE DChief Operating Officer02/11/20192,460,995
GIVEN BRUCE DChief Operating Officer02/08/2019708,202
GIVEN BRUCE DChief Operating Officer02/12/2019725,050
GIVEN BRUCE DChief Operating Officer02/05/2019325,800
GIVEN BRUCE DChief Operating Officer02/01/2019394,725
GIVEN BRUCE DChief Operating Officer01/23/2019230,125
GIVEN BRUCE DChief Operating Officer01/22/20192,065,680
GIVEN DOUGLAS BDirector01/22/201940,740
O'Brien PatrickGeneral Counsel01/18/20191,038,960
Myszkowski Kenneth AllenChief Financial Officer01/17/20191,191,281
Li ZhenSnr. VP, Chem and Non-Clin Dev01/14/2019580,770
GIVEN BRUCE DChief Operating Officer01/14/201936,765
GIVEN BRUCE DChief Operating Officer01/14/2019614,390
Waddill William D.Director01/11/2019125,545
Myszkowski Kenneth AllenChief Financial Officer01/02/201999,829
GIVEN BRUCE DChief Operating Officer01/02/2019239,600
GIVEN DOUGLAS BDirector12/27/201836,000
Anzalone Christopher RichardChief Executive Officer12/19/20181,252,800
Anzalone Christopher RichardChief Executive Officer12/12/20181,266,300
GIVEN DOUGLAS BDirector11/23/201838,220
Anzalone Christopher RichardChief Executive Officer11/09/20181,172,705
Leone Peter BrianVP, Strategic Bus. Initiatives10/19/2018812,512
Leone Peter BrianVP, Strategic Bus. Initiatives10/19/20181,769,038
Myszkowski Kenneth AllenChief Financial Officer09/06/2018160,500
Myszkowski Kenneth AllenChief Financial Officer09/06/2018870,200
Anzalone Christopher RichardChief Executive Officer09/04/2018936,851
Anzalone Christopher RichardChief Executive Officer08/31/20181,445,000
Myszkowski Kenneth AllenChief Financial Officer06/19/201840,200
Myszkowski Kenneth AllenChief Financial Officer06/19/2018280,200
Myszkowski Kenneth AllenChief Financial Officer05/30/20182,814
Myszkowski Kenneth AllenChief Financial Officer05/31/201825,326
Myszkowski Kenneth AllenChief Financial Officer05/30/201815,400
Myszkowski Kenneth AllenChief Financial Officer05/31/2018138,600
GIVEN DOUGLAS BDirector04/24/2018165,750
Myszkowski Kenneth AllenChief Financial Officer03/27/201840,200
Myszkowski Kenneth AllenChief Financial Officer03/27/2018160,000
Anzalone Christopher RichardChief Executive Officer03/16/2018192,400
Anzalone Christopher RichardChief Executive Officer03/14/2018744,000
Anzalone Christopher RichardChief Executive Officer03/13/2018743,000
Anzalone Christopher RichardChief Executive Officer03/15/2018741,000
GIVEN BRUCE DChief Operating Officer03/05/2018134,600
Myszkowski Kenneth AllenChief Financial Officer03/05/201854,665
GIVEN BRUCE DChief Operating Officer01/01/201873,800
Anzalone Christopher RichardChief Executive Officer12/13/2016381,564
GIVEN DOUGLAS BDirector10/14/201680,640
Myszkowski Kenneth AllenChief Financial Officer08/23/201613,869
Myszkowski Kenneth AllenChief Financial Officer08/22/201626,331
Myszkowski Kenneth AllenChief Financial Officer08/23/201655,200
Myszkowski Kenneth AllenChief Financial Officer08/22/2016104,800
Myszkowski Kenneth AllenChief Financial Officer08/22/201626,331
Myszkowski Kenneth AllenChief Financial Officer08/23/201613,869
Myszkowski Kenneth AllenChief Financial Officer08/22/2016104,800
Myszkowski Kenneth AllenChief Financial Officer08/23/201655,200
Anzalone Christopher RichardChief Executive Officer06/30/201680,279
Myszkowski Kenneth AllenChief Financial Officer03/04/201627,119
GIVEN BRUCE DChief Operating Officer03/04/201659,213
Myszkowski Kenneth AllenChief Financial Officer02/06/201645,146
GIVEN BRUCE DChief Operating Officer02/06/201662,173
Myszkowski Kenneth AllenChief Financial Officer12/30/201580,628
Myszkowski Kenneth AllenChief Financial Officer12/30/2015143,117
Anzalone Christopher RichardChief Executive Officer12/30/2015359,905
Ferrari MauroDirector10/28/20133,047
Ferrari MauroDirector10/09/201311,761
Lewis David L.Chief Scientific Officer01/05/201530,150
Lewis David L.Chief Scientific Officer01/05/2015120,103
Anzalone Christopher RichardPresident and CEO10/15/2014101,120
Anzalone Christopher RichardPresident and CEO10/15/2014101,120
McKenney CharlesDirector10/01/201412,975
McKenney CharlesDirector10/01/201436,748
Lewis David L.Chief Scientific Officer09/30/201430,150
Lewis David L.Chief Scientific Officer09/30/2014225,350
GIVEN DOUGLAS BDirector09/26/20144,380
GIVEN DOUGLAS BDirector09/26/201430,480
GIVEN DOUGLAS BDirector08/15/201410,050
GIVEN DOUGLAS BDirector08/15/201469,500
Myszkowski Kenneth AllenCFO08/15/2014252,850
Myszkowski Kenneth AllenCFO08/15/2014560,860
McKenney CharlesDirector06/09/201452,480
McKenney CharlesDirector06/09/2014315,005
Myszkowski Kenneth AllenCFO02/12/201432,160
Myszkowski Kenneth AllenCFO02/12/2014300,290
FRYKMAN EDWARD WDirector02/07/201450,000
FRYKMAN EDWARD WDirector02/07/201450,296
Lewis David L.Chief Scientific Officer01/02/201465,525
Lewis David L.Chief Scientific Officer01/02/2014154,292
McKenney CharlesDirector10/11/20139,096
Anzalone Christopher RichardPresident and CEO08/31/20108,900
Anzalone Christopher RichardPresident and CEO08/27/20108,900
Myszkowski Kenneth AllenCFO08/27/201013,350
Load More Insider Transactions
FUNDS WITH A POSITION IN ARROWHEAD PHARMACEUTICALS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.13,303,7570.01%3.62%Other
GEODE CAPITAL MANAGEMENT, LLC2,326,8760.00745%4.9%Other
ORBIMED ADVISORS LLC319,6510.2%-26.29%Other
CANDRIAM S.C.A.185,0540.04%-15.91%Other
WCM INVESTMENT MANAGEMENT, LLC172,8650.01%13.56%Growth At A Reasonable Price
VIVO CAPITAL, LLC137,4110.34%No changeOther
RENAISSANCE TECHNOLOGIES LLC122,0000.00578%-68.02%Other
PLATINUM INVESTMENT MANAGEMENT LTD97,1680.12%No changeGrowth At A Reasonable Price, Value
D. E. SHAW & CO., INC.45,4740.00122%NewOther
DRIEHAUS CAPITAL MANAGEMENT LLC29,4930.01%No changeGrowth
TUDOR INVESTMENT CORP ET AL10,6010.00261%NewEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR ARROWHEAD PHARMACEUTICALS INC.
STOCK BUYBACKS FOR ARROWHEAD PHARMACEUTICALS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.19%
1Q
12/31/2023
06/30/2023
0.38%
2Q
12/31/2023
03/31/2023
-0.67%
3Q
12/31/2023
12/31/2022
1.30%
4Q
12/31/2023
09/30/2022
1.44%
5Q
12/31/2023
06/30/2022
1.57%
6Q
12/31/2023
03/31/2022
-0.48%
7Q
12/31/2023
12/31/2021
2.76%
8Q
12/31/2023
09/30/2021
3.01%
9Q
12/31/2023
06/30/2021
3.19%
10Q
12/31/2023
03/31/2021
3.42%
11Q
12/31/2023
12/31/2020
4.53%
12Q
12/31/2023
09/30/2020
4.96%
13Q
12/31/2023
06/30/2020
5.47%
14Q
12/31/2023
03/31/2020
5.67%
15Q
12/31/2023
12/31/2019
10.63%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.19%
1Q
06/30/2023
0.38%
2Q
03/31/2023
-0.67%
3Q
12/31/2022
1.30%
4Q
09/30/2022
1.44%
5Q
06/30/2022
1.57%
6Q
03/31/2022
-0.48%
7Q
12/31/2021
2.76%
8Q
09/30/2021
3.01%
9Q
06/30/2021
3.19%
10Q
03/31/2021
3.42%
11Q
12/31/2020
4.53%
12Q
09/30/2020
4.96%
13Q
06/30/2020
5.47%
14Q
03/31/2020
5.67%
15Q
12/31/2019
10.63%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ARROWHEAD PHARMACEUTICALS INC.
LOADING...